SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-12-004445
Filing Date
2012-05-03
Accepted
2012-05-03 16:05:12
Documents
14
Period of Report
2012-05-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K pdl_8k-050312.htm 8-K 34881
2 EXHIBIT 99.1 ex99-1.htm EX-99.1 157323
3 EXHIBIT 99.2 ex99-2.htm EX-99.2 7471
4 EXHIBIT 99.3 ex99-3.htm EX-99.3 30584
5 EXHIBIT 99.4 ex99-4.htm EX-99.4 538846
6 logo.jpg GRAPHIC 23080
7 a1.jpg GRAPHIC 63199
8 a2.jpg GRAPHIC 149454
9 a3.jpg GRAPHIC 64390
10 a4.jpg GRAPHIC 83066
11 a5.jpg GRAPHIC 71319
12 a6.jpg GRAPHIC 69278
13 a7.jpg GRAPHIC 81061
14 a8.jpg GRAPHIC 92410
  Complete submission text file 0001437749-12-004445.txt   1732001
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 12809659
SIC: 2836 Biological Products, (No Diagnostic Substances)